ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
FDA halts approval process due to government shutdown pharmafile
January 16, 2019California-based biopharmaceutical firm, Aimunne Therapeutics has been notified that due to the government shutdown, the US Food and Drug Administration (FDA) will not review the company’s Biologics License Application (BLA) for its investigational peanut
Pharma Sources Insight July 2025
